Interventional Pain Management Market Overview
The report is titled ‘Interventional Pain Management Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual Interventional Pain Management Works, analytical approaches of the Interventional Pain Management market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The interventional pain management market is expected to grow at a significant rate in the near future.
The global interventional pain management market is estimated to reach at a value of US$ xx Mn by the end of 2020 and expected to reach at a value of US$ xx Mn by 2028 with a significant CAGR of xx%
Interventional Pain Management Introduction
Interventional pain management can be understood as a pain-relieving therapy that comprises operations such as pain-relieving infusions and spinal cord stimulus. At pain management centers or clinics, the expertise and proficient anesthesiologists manage interventional pain control therapies and treatments.
Diabetic neuropathy, joint pain, ankle and foot pain, neck and back pain, and cancer pain are among the medical conditions for which these treatments are generally employed. What makes interventional pain management distinct from other treatments is that it employs methods, such as injections and radiofrequency rhizotomy, to straightaway address the root cause of the pain.
Interventional Pain Management Market Dynamics
The swiftly growing prevalence of chronic pain among the population is primarily propelling the demand of interventional pain management techniques all across the world. To support that, according to the Centers for Disease Control and Prevention, in the year 2019, about 20.4% of adults suffered from chronic pain and 7.4% of adults were undergoing chronic pain that oftentimes restricted their life or work activities in the past 3 months.
Another study revealed that the prevalence rate of chronic pain in young adults is approximately 11.6%, proposing that 1 in every 9 young adults suffer from chronic pain around the world. Attributing to which, the global interventional pain management market is projected to witness significant growth over the forecast period.
In addition to that, the sedentary lifestyle of the individuals, in the present times, with almost no physical activities and desk-bound jobs as well as poor diet is further encouraging the incidence of chronic pain among adults in recent years. Owing to which, the global interventional pain management market is projected to grow higher in the coming years.
Interventional Pain Management Market Segmentation
The global interventional pain management market is segmented on the basis of technique, application and region.
By Technique
Pain Management Injection
Epidural Steroid Injections
Facet Joint Injections
Medial Branch Blocks
Nerve Blocks
Sacroiliac Injections
Trigger Point Injections
Others
Radiofrequency Ablation
Spinal Cord Stimulation
Others
By Application
Back and Neck Pain
Diabetic Neuropathy
Cancer Pain
Foot and Ankle Pain
Joint Pain
Muscle Pain and Spasm
Post-Injury Pain
Shingles Pain
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Interventional Pain Management Market Key Players
The key participating players of the global interventional pain management market include Ipsen group, Allergan Plc., Medytox Inc., Merz GmbH, Medtronic Plc., Boston Scientific Corporation, and St. Jude Medical, Inc., among others.
Reports & Insights Overview on Interventional Pain Management Market Report
The non-identical approach of Reports & Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the Interventional Pain Management market by Reports & Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of Interventional Pain Management
Advantages of Interventional Pain Management
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment where one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
To learn more about this report, request a free sample copy
The interventional pain management market is estimated to reach at a value of US$ *** Mn by the end of 2022 and expected to reach at a value of US$ *** Mn by 2030 with a significant CAGR of ***%.
The base year for the report is 2021 in interventional pain management market.
The global interventional pain management market is segmented on the basis of technique, application and region.
The key participating players of the global interventional pain management market include Ipsen group, Allergan Plc., Medytox Inc., Merz GmbH, Medtronic Plc., Boston Scientific Corporation, and St. Jude Medical, Inc., among others.